Abstract
Several lines of evidence show that blood pressure (BP) control in treated hypertensive patients is largely unsatisfactory and that this depends on a variety of factors, such as the poor patient’s compliance, insufficient use of combination drug treatment as well as true difficulties in achieving well controlled BP. This review article will be focused on the main features of BP control by discussing the data obtained in clinical trials as well as the results available in clinical practice. The paper will also discuss the possible factors responsible for these findings as well as the favourable outcome on cardiovascular risk profile of an effective control of elevated BP. The possible approaches for controlling elevated BP values will be highlighted.
Keywords: Hypertension, antihypertensive treatment, blood pressure control, treatment compliance, clinical trials, cardiovascular risk, ACE-inhibitor, beta-blocker, metabolic disorders, cerebrovascular disease
Current Vascular Pharmacology
Title:Blood Pressure Control and Antihypertensive Treatment
Volume: 10 Issue: 4
Author(s): Guido Grassi, Gino Seravalle, Fosca Quarti Trevano, Raffaella Dell’Oro and Giuseppe Mancia
Affiliation:
Keywords: Hypertension, antihypertensive treatment, blood pressure control, treatment compliance, clinical trials, cardiovascular risk, ACE-inhibitor, beta-blocker, metabolic disorders, cerebrovascular disease
Abstract: Several lines of evidence show that blood pressure (BP) control in treated hypertensive patients is largely unsatisfactory and that this depends on a variety of factors, such as the poor patient’s compliance, insufficient use of combination drug treatment as well as true difficulties in achieving well controlled BP. This review article will be focused on the main features of BP control by discussing the data obtained in clinical trials as well as the results available in clinical practice. The paper will also discuss the possible factors responsible for these findings as well as the favourable outcome on cardiovascular risk profile of an effective control of elevated BP. The possible approaches for controlling elevated BP values will be highlighted.
Export Options
About this article
Cite this article as:
Grassi Guido, Seravalle Gino, Quarti Trevano Fosca, Dell’Oro Raffaella and Mancia Giuseppe, Blood Pressure Control and Antihypertensive Treatment, Current Vascular Pharmacology 2012; 10 (4) . https://dx.doi.org/10.2174/157016112800812719
DOI https://dx.doi.org/10.2174/157016112800812719 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Calcium Metabolism and Oxidative Stress in Bone Fractures: Role of Antioxidants
Current Drug Metabolism Current Status of Renal Arterial Endovascular Interventions
Current Hypertension Reviews Lysosomal Modulatory Drugs for a Broad Strategy Against Protein Accumulation Disorders
Current Alzheimer Research Conference Report: The Myriad Pathways of Neurodegeneration Discussed at NEUROCON 2015
Current Aging Science Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinsons Disease
Current Neuropharmacology Pleiotropic Effects of Statin in Therapy in Heart Failure: A Review
Current Vascular Pharmacology A Journey through Genetic Architecture and Predisposition of Coronary Artery Disease
Current Genomics Limiting Functional Deficiency Following Stroke: Exploiting Different Stem Cell Reservoirs
Current Neuropharmacology Tyrosine Hydroxylase Gene: Another Piece of the Genetic Puzzle of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Gender and Cardiovascular Mortality in Northern and Southern European Populations
Current Pharmaceutical Design The Role of C-Reactive Protein in Atherosclerotic Cardiovascular Disease: An Overview
Current Vascular Pharmacology Drug-Induced Thromboembolic Events in Patients with Malignancy
Cardiovascular & Hematological Disorders-Drug Targets Insulin Secretagogues, Sulfonylurea Receptors and KATP Channels
Current Pharmaceutical Design Therapeutic Applications of Crocus sativus L. (Saffron): A Review
The Natural Products Journal The Concept of “Neuroprotection” in Neurological Diseases
Current Neuropharmacology Targeting the Alpha 7 Nicotinic Acetylcholine Receptor to Reduce Amyloid Accumulation in Alzheimers Disease Pyramidal Neurons
Current Pharmaceutical Design Statins and Ischaemia Reperfusion Injury: A Molecular Biological Review
Current Vascular Pharmacology Chronic Kidney Disease and Urological Disorders: An Overview
Current Signal Transduction Therapy Impact of Aging on the Angiogenic Potential of the Myocardium: Implications for Angiogenic Therapies with Emphasis on Sirtuin Agonists
Recent Patents on Cardiovascular Drug Discovery Relationship Between the Chemokine Receptor CCR5 and Microglia in Neurological Disorders: Consequences of Targeting CCR5 on Neuroinflammation, Neuronal Death and Regeneration in a Model of Epilepsy
CNS & Neurological Disorders - Drug Targets